US Patent 9240043 Reproducible quantification of biomarker expression
Patent 9240043 was granted and assigned to Novartis on January, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9240043 Reproducible quantification of biomarker expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
